ERBB2 and melanoma: Desmoplastic melanomas are often associated with a higher mutational burden and genomic profiles often associated with desmoplastic melanoma include inactivating mutations in NF1, promoter mutations in NFKBIE, and diverse activating mutations in the MAP kinase pathway, including those in ERBB2, MAP2K1, and MAP3K1 [21].